Department of Urology, Foundation IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
Division of Experimental Oncology/Unit of Urology; URI; IRCCS Ospedale San Raffaele, Milan, Italy.
PLoS One. 2023 Jan 19;18(1):e0280519. doi: 10.1371/journal.pone.0280519. eCollection 2023.
To investigate which infertile men with semen parameters above WHO reference limits at first semen analysis deserve a second semen test.
Data from 1358 consecutive infertile men were analysed. Patients underwent two consecutive semen analyses at the same laboratory. Descriptive statistics and logistic regression models tested the association between clinical variables and semen parameters. A new predicting model was identified through logistic regression analysis exploring potential predictors of semen parameters below WHO reference limits after a previously normal one. Diagnostic accuracy of the new model was compared with AUA/ASRM and EAU guidelines. Decision curve analyses (DCA) tested their clinical benefit.
Of 1358, 212 (15.6%) infertile men had semen parameters above WHO reference limits at first analysis. Of 212, 87 (41.0%) had a second semen analysis with results above WHO reference limits. Men with sperm parameters below reference limits at second analysis had higher FSH values, but lower testicular volume (TV) (all p<0.01) compared to men with a second semen analysis above WHO limits. At multivariable logistic regression analysis, lower TV (OR 0.9, p = 0.03), higher FSH (OR 1.2, p<0.01), and lower total sperm count (OR 0.9, p<0.01) were associated with second semen analyses below WHO limits. DCA showed the superior net benefit of using the new model, compared to both AUA/ASRM and EAU guidelines to identify those men with a second semen sample below WHO limits after a previously normal one.
Approximately 60% of infertile men with a first semen analysis above WHO limits have a second analysis with results below limits. The newly identified risk model might be useful to select infertile men with initial semen results above WHO limits who deserve a second semen analysis.
探讨首次精液分析精液参数高于世界卫生组织(WHO)参考值的不育男性中,哪些人需要进行第二次精液检查。
对 1358 例连续不育男性患者的数据进行分析。患者在同一家实验室进行了两次连续的精液分析。采用描述性统计和逻辑回归模型,检验了临床变量与精液参数之间的关联。通过逻辑回归分析,确定了一个新的预测模型,该模型探索了首次正常精液分析后精液参数低于 WHO 参考值的潜在预测因素。新模型的诊断准确性与 AUA/ASRM 和 EAU 指南进行了比较。决策曲线分析(DCA)测试了它们的临床获益。
在 1358 例不育男性中,212 例(15.6%)首次精液分析精液参数高于 WHO 参考值。在这 212 例患者中,87 例(41.0%)进行了第二次精液分析,结果仍高于 WHO 参考值。与第二次精液分析高于 WHO 参考值的男性相比,第二次精液分析结果低于参考值的男性 FSH 值较高,但睾丸体积(TV)较低(均 p<0.01)。多变量逻辑回归分析显示,较低的 TV(OR 0.9,p=0.03)、较高的 FSH(OR 1.2,p<0.01)和较低的总精子数(OR 0.9,p<0.01)与第二次精液分析低于 WHO 参考值有关。DCA 显示,与 AUA/ASRM 和 EAU 指南相比,使用新模型来识别首次正常精液分析后第二次精液分析低于 WHO 参考值的男性,具有更高的净获益。
大约 60%首次精液分析高于 WHO 参考值的不育男性第二次精液分析结果低于参考值。新确定的风险模型可能有助于选择首次精液分析结果高于 WHO 参考值的不育男性,这些男性需要进行第二次精液分析。